or Try an Advanced Search...

    Technical Analysis for GRCE - Grace Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 3.24 -3.86% -0.13
    GRCE closed down 3.86 percent on Tuesday, October 29, 2024, on 74 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: Nov 11
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical GRCE trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Gapped Down Weakness 0.00%
    20 DMA Support Bullish -3.86%
    Calm After Storm Range Contraction -3.86%
    MACD Bearish Signal Line Cross Bearish -4.71%
    Jack-in-the-Box Bullish Bullish Swing Setup -4.71%
    Older End-of-Day Signals for GRCE ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support 4 days ago
    Down 5% 4 days ago
    Down 3% 4 days ago
    Fell Below Previous Day's Low 4 days ago
    Down 2 % 4 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    GRCE Chart by TradingView
    Basic chart:

    Profile

    Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002, and is headquartered in Princeton, NJ.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Pharmacy Medication Cardiovascular Disease Pharmaceutical Applications

    Is GRCE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 29 OTC Markets Hosts Virtual Investor Presentation with Prashant Kohli, CEO of Grace Therapeutics (Acasti Pharma), with John Vandermosten, Senior Analyst at Zacks SCR
    Oct 25 Acasti Pharma changes name to Grace Therapeutics
    Oct 25 Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
    Sep 25 Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
    Sep 20 Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
    Sep 16 Life Sciences Virtual Investor Forum Agenda Announced for September 19th
    Sep 5 Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 9 Acasti Pharma GAAP EPS of -$0.24
    Aug 9 Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
    Jul 10 Is Acasti Pharma (ACST) Outperforming Other Medical Stocks This Year?
    See more GRCE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.6
    52 Week Low 1.98
    Average Volume 32,388
    200-Day Moving Average 2.92
    50-Day Moving Average 2.85
    20-Day Moving Average 3.26
    10-Day Moving Average 3.35
    Average True Range 0.21
    RSI (14) 53.05
    ADX 28.83
    +DI 21.23
    -DI 14.47
    Chandelier Exit (Long, 3 ATRs) 2.96
    Chandelier Exit (Short, 3 ATRs) 3.41
    Upper Bollinger Bands 3.57
    Lower Bollinger Band 2.94
    Percent B (%b) 0.48
    BandWidth 19.21
    MACD Line 0.14
    MACD Signal Line 0.16
    MACD Histogram -0.02
    Fundamentals Value
    Market Cap 30.45 Million
    Num Shares 9.4 Million
    EPS -5.65
    Price-to-Earnings (P/E) Ratio -0.57
    Price-to-Sales 208.39
    Price-to-Book 0.35
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.48
    Resistance 3 (R3) 3.46 3.37 3.44
    Resistance 2 (R2) 3.37 3.31 3.38 3.42
    Resistance 1 (R1) 3.31 3.27 3.34 3.32 3.41
    Pivot Point 3.21 3.21 3.23 3.22 3.21
    Support 1 (S1) 3.15 3.15 3.18 3.16 3.07
    Support 2 (S2) 3.05 3.11 3.06 3.06
    Support 3 (S3) 2.99 3.05 3.04
    Support 4 (S4) 3.00